Humacyte Announces Presentation of First Preclinical
DURHAM, N.C., Jan. 04, 2022 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally...
United States Laura Niklason Alanp Kypson Humacyte Inc Fresenius Medical Care Human Acellular Vessel
Source: globenewswire.com